advertisement
AIM: To determine the incidence of ocular toxicity of preservatives with glaucoma medications. METHODS: A prospective epidemiological survey was carried out in 1999 by 249 ophthalmologists on 4107 patients. Ocular symptoms, conjunctiva, cornea, and eyelids were assessed. A Χ2 test was used for differences between preserved eye drops (P) and preservative free eye drops (PF). RESULTS: Eighty-four percent of patients used P, 13% received PF, and 3% a combination of P and PF eye drops. All symptoms were more prevalent with P than with PF drops (p < 0.001): discomfort upon instillation (43 versus 17%), and symptoms between instillations such as burning-stinging (40 versus 22%), foreign body sensation (31 versus 14%), dry eye sensation (23 versus 14%), tearing (21 versus 14%), and eyelid itching (18 versus 10%). An increased incidence (> 2 times) of ocular signs was seen with P eye drops. The prevalence of signs and symptoms was dose dependent, increasing with the number of P drops. A reduction in the symptoms and signs was observed when patients changed from P to PF eye drops (p < 0.001). CONCLUSIONS: Symptoms and signs are less prevalent when PF drops are used. Moreover, most of the adverse reactions induced by P glaucoma medication are reversible after removing preservatives.
Dr. P.J. Pisella, APHP Ambroise Pare Hospital, University Paris V, Ophthalmology Department, 9, avenue Charles de Gaulle, 92100 Boulogne, France
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (Part of: 11 Medical treatment)